CPBT consortium lands €124,5 million funding.
Last year, Allegro became part of the CPBT. The new Centre for Animal-Free Biomedical Translation (CPBT) aims to accelerate the transition to […]
Last year, Allegro became part of the CPBT. The new Centre for Animal-Free Biomedical Translation (CPBT) aims to accelerate the transition to […]
The article discusses the rise of biotech companies in and around Liège, with a special focus on LégiaPark, a new hub for […]
At the prestigious BIO CEO & Investor Conference, Allegro and its CEO, Lucas Decuypere, seized the spotlight with an inspiring keynote address. […]
Allegro Biotech’s CEO, Lucas Decuypere, took center stage at the prestigious Discovery in Animal Health (DIAH) conference in Ghent, delivering a captivating […]
Allegro: Crowned Top 10 Biotech Company by LifeSciences Review In a resounding testament to its pioneering efforts in biomedical technologies, Allegro has […]
Allegro raises €5,5M in funding to complete their breakthrough treatment for osteoarthritis Allegro, The Belgian specialist in biomedical nanotechnology is excited to […]
Allegro is proud to have been contacted by At.las and become a member. At.las (Leveraging Affordable Solutions for Advanced Therapies) is a young […]
Allegro pitched at the State of the Union at Flanders.bio Knowledge For Growth.
Our open house at Bluechem was a tremendous success. We welcomed notable attendees from government, ngo’s, financial institutions and research. A great […]
Read the story of our founder Jorg Schelfhout and his journey as an entrepreneur. In the article, Jorg also walks through the […]